Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.
- DOI
- 10.1038/s41408-026-01510-1
- Published
- 2026-04-22
- Container
- Blood Cancer Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-026-01510-1,
title = {Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.},
author = {Joshua N. Gustine and Narsis Attar and Benjamin R. Puliafito and Diana D. Cirstea and Andrew R. Branagan and Andrew J. Yee and Noopur S. Raje},
year = {2026},
journal = {Blood Cancer Journal},
doi = {10.1038/s41408-026-01510-1},
url = {https://doi.org/10.1038/s41408-026-01510-1}
}RIS
TY - JOUR TI - Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T. AU - Joshua N. Gustine AU - Narsis Attar AU - Benjamin R. Puliafito AU - Diana D. Cirstea AU - Andrew R. Branagan AU - Andrew J. Yee AU - Noopur S. Raje PY - 2026 JO - Blood Cancer Journal DO - 10.1038/s41408-026-01510-1 UR - https://doi.org/10.1038/s41408-026-01510-1 ER -
APA
Gustine, J. N., Attar, N., Puliafito, B. R., Cirstea, D. D., Branagan, A. R., Yee, A. J., & Raje, N. S. (2026). Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01510-1
Source records
- crossref · retrieved 2026-09-27T01:33:57.538Z